New lens showdown: which IOL gives sharper sight after cataracts?
NCT ID NCT07262021
First seen Jan 05, 2026 · Last updated Jun 19, 2026 · Updated 28 times
Summary
This study will compare two enhanced monofocal intraocular lenses (IOLs) used in cataract surgery to see which one provides better vision at intermediate distances, like reading a computer screen. Thirty adults with age-related cataracts will receive one of the two lenses, and their vision will be tested before and after surgery. The goal is to find out if one lens offers clearer sight without glasses for everyday tasks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vienna Institute for Research in Ocular Surgery
Vienna, 1140, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
enhanced monofocal intraocular lens (IOL)
What this could lead to
If successful, this could help cataract patients see better at intermediate distances (like arm's length) without needing glasses.
What could go wrong
This is a small, early-stage study with only 30 people, so results may not apply to everyone. It compares two similar lenses, so major breakthroughs are unlikely.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.